Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accendra HealthACH +0.68%59 EV-to-OCF is -17.64 as of Aug. 05, 2026. GuruFocus rates ACH with a GF Score™ of 59/100 and a GF Value™ of $5.44 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 118 Medical Distribution companies, Accendra Health ranks better than 87.29% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Accendra Health's Enterprise Value is $2,060 Mil.
Accendra Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-117 Mil. Therefore, Accendra Health's EV-to-OCF for today is -17.64.
The historical rank and industry rank for Accendra Health's EV-to-OCF or its related term are showing as below:
ACH'
s EV-to-OCF Range Over the Past 10 Years
Min: -26.16 Med: 14.11 Max: 55.19
Current: -17.64
During the past 13 years, the highest EV-to-OCF of Accendra Health was 55.19. The lowest was -26.16. And the median was 14.11.
ACH's EV-to-OCF is ranked better than 87.29% of 118
companies
in the Medical Distribution industry
Industry Median: 7.765
vs ACH: -17.64
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Accendra Health's PE Ratio (TTM) for today is calculated as:
Accendra Health's share price for today is $2.96.
Accendra Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.050.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Accendra Health EV-to-OCF Related Terms
Accendra Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Accendra Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Accendra Health's EV-to-OCF falls into.
Accendra Health's current Enterprise Value is $2,060 Mil.
Accendra Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-117 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a EV-to-OCF of -17.64 as of Aug. 05, 2026. According to the industry distribution chart, Accendra Health ranks #15 out of 118 companies in the Medical Distribution industry, placing it in the top 12.7%.
Is Accendra Health's EV-to-OCF too high?
Accendra Health's current EV-to-OCF is -17.64. Based on the distribution chart, Accendra Health ranks #15 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Accendra Health has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's EV-to-OCF compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #15 out of 118 companies for EV-to-OCF. This places Accendra Health in the top 13% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 7.77, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 7.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current EV-to-OCF is -17.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.44, compared to a current price of $2.96 — trading 45.6% below its estimated fair value. The current EV-to-OCF is -17.64. Accendra Health's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Accendra Health (ACH), the current EV-to-OCF is -17.64 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $2.96 is trading 45.6% below its estimated GF Value™ of $5.44.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
EV-to-OCF: -17.64
GF Value™: $5.44 vs. price of $2.96 (45.6% below fair value)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
59GF Score
Get the complete analysis for ACH
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
